These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7977489)

  • 1. Renal function does not always predictably deteriorate in blind insulin-dependent diabetics with nephropathy.
    Edwards BD; McHale J; Newstead C; Ballardie FW
    Am J Nephrol; 1994; 14(3):233-5. PubMed ID: 7977489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in insulin-dependent diabetes.
    Norgaard K
    Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy.
    Kofoed-Enevoldsen A; Jensen T; Borch-Johnsen K; Deckert T
    J Diabet Complications; 1987; 1(3):96-9. PubMed ID: 2969913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
    Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure disturbance in diabetes mellitus.
    Zanella MT; Freire MB; Milagres R; Ferreira S; Bonomo PP; Kohlmann O; Ribeiro AB
    J Hypertens Suppl; 1992 Dec; 10(7):S59-70. PubMed ID: 1291658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pregnancy alter the rate of progression of diabetic nephropathy?
    Reece EA; Winn HN; Hayslett JP; Coulehan J; Wan M; Hobbins JC
    Am J Perinatol; 1990 Apr; 7(2):193-7. PubMed ID: 2331283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy: natural history and declining incidence in diabetic children.
    Christlieb AR
    J Diabet Complications; 1988; 2(4):167-70. PubMed ID: 2976759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Microangiopathies of diabetics (epidemiologic and clinical observations].
    Tornóczky J; Vastag O; Sziládi E; Kottmayer K; Muth L; Rucker R
    Orv Hetil; 1987 Jan; 128(3):137-40, 143-4. PubMed ID: 3562010
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
    Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
    Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress.
    Lopes de Faria JB; Silva KC; Lopes de Faria JM
    Hypertens Res; 2011 Apr; 34(4):413-22. PubMed ID: 21228783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hypertension on prognosis in IDDM.
    Hasslacher C; Borgholte G; Ritz E; Wahl P
    Diabete Metab; 1989; 15(5 Pt 2):338-42. PubMed ID: 2693153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between arterial hypertension and diabetic nephropathy].
    Passa P; Marre M; Leblanc H
    Presse Med; 1987 Dec; 16(44):2221-5. PubMed ID: 2963317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes.
    Schmechel H; Heinrich U
    Diabete Metab; 1993; 19(1 Pt 2):138-42. PubMed ID: 8314417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of intrarenal hemodynamics in glomerulopathies].
    Kutyrina IM; Tareeva IE; Shestakova MV; Zverev KV
    Vestn Ross Akad Med Nauk; 1995; (5):47-52. PubMed ID: 7626986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-diabetic renal disease in patients with type 2 diabetes mellitus.
    Prakash J; Sen D; Usha ; Kumar NS
    J Assoc Physicians India; 2001 Apr; 49():415-20. PubMed ID: 11762610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.